Dimensional Fund Advisors LP Logic Bio Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

  • $403 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$0.61 - $2.49 $14,870 - $60,701
-24,378 Closed
0 $0
Q4 2021

Feb 09, 2022
BUY
$2.2 - $4.53 $7,231 - $14,890
3,287 Added 15.58%
24,378 $56,000
Q3 2021

Nov 12, 2021
SELL
$3.85 - $5.09 $27,254 - $36,032
-7,079 Reduced 25.13%
21,091 $97,000
Q2 2021

Aug 12, 2021
BUY
$4.03 - $7.57 $113,525 - $213,246
28,170 New
28,170 $125,000

About LogicBio Therapeutics, Inc.

LOGC Quotes by TradingView
  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email